We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
"The majority of research teams will finish preparations for clinical trials by April and are expected to successively roll out applications for clinical trials," Wang said.
The U.S. Food and Drug Administration released a final guidance, "Postmarketing Safety Reporting for Combination Products," for applicants of combination products